Test Price
1,800 AED✅ Home Collection Available
Plasma Cell Dyscrasia Flow Cytometry Panel (Bone Marrow) in UAE | 1800 AED | DHA Licensed
Executive Summary & Core Metrics
This advanced immunophenotyping panel detects clonal plasma cells in bone marrow aspirate with diagnostic sensitivity exceeding 99.9% via ISO-accredited multicolor flow cytometry (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139). The assay delivers quantitative and qualitative data essential for diagnosing multiple myeloma, plasmacytoma, and related monoclonal gammopathies.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Plasma Cell Dyscrasia Flow Cytometry Panel utilizes 10-color immunophenotyping per EuroFlow consensus to identify and quantify abnormal plasma cell populations in bone marrow aspirate. The panel targets surface and intracellular markers including CD138, CD38, CD45, CD19, CD56, cytoplasmic kappa, and cytoplasmic lambda light chains. This approach enables detection of clonal plasma cells at a sensitivity threshold of 0.01%, providing critical diagnostic and prognostic information for hematologic malignancies.
| Parameter | Our Test (Plasma Cell Dyscrasia Flow Panel) | Closest Alternative (Serum Protein Electrophoresis + Immunofixation) |
|---|---|---|
| Precision | 10-color flow cytometry per EuroFlow consensus; detects ≥0.01% clonal plasma cells | Semi-quantitative; detection limit ~500 mg/L M-protein |
| Methodology | Multicolor Immunophenotyping (CD138/CD38/CD45/CD19/CD56/cyKappa/cyLambda) | Electrophoresis & Immunofixation |
| Turnaround Time | 1–2 days | 3–5 days |
| Sample | Bone Marrow Aspirate (iliac crest or guided) | Peripheral Blood / Urine |
Physician Insight & Safety Protocols
“Flow cytometry immunophenotyping provides a granular view of plasma cell clonality that cannot be achieved through serum protein studies alone. However, these results must always be correlated with bone marrow histology, serum free light chain assays, and the patient’s complete clinical picture. Accurate diagnosis requires integration of all modalities.” – Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Mandatory Safety Advisory
Do not discontinue prescribed medication without consulting your doctor.
- Exclusion: Active systemic infection, uncorrected coagulopathy, pregnancy without explicit clinical indication.
- ER Red Flags: Severe pain at biopsy site, fever above 38.5°C, uncontrolled bleeding, or sudden shortness of breath within 24 hours post-procedure—seek immediate emergency care.
- Inform clinical team about anticoagulant or antiplatelet use before scheduling.
Patient Exclusion Criteria
This test is contraindicated in patients with uncorrected bleeding diatheses, severe thrombocytopenia (platelet count below 20,000/µL), or hemodynamic instability. A valid doctor’s prescription is mandatory. Bone marrow aspiration is not performed for surgical clearance, routine wellness screening, or travel health certificates without direct hematologic indication.
Patient FAQ & Clinical Guidance
1. What is a Plasma Cell Dyscrasia Flow Cytometry test?
This advanced diagnostic panel uses fluorescently labeled antibodies to identify and quantify abnormal plasma cells in bone marrow aspirate. It detects clonal populations at very low levels (0.01%), enabling early and accurate diagnosis of multiple myeloma, plasmacytoma, and other monoclonal gammopathies.
2. How should I prepare for the bone marrow aspiration?
No special dietary preparation is required. You must provide a valid doctor’s prescription and inform the clinical team about any blood-thinning medications or anticoagulants. The procedure is performed under local anesthesia and sedation as needed.
3. What do abnormal results mean?
Elevated percentages of clonal plasma cells indicate a monoclonal gammopathy, which may represent multiple myeloma, smoldering myeloma, or monoclonal gammopathy of undetermined significance (MGUS). Further evaluation by a hematologist including serum free light chain analysis, skeletal survey, and bone marrow histology is required for definitive diagnosis and staging.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Governance Framework
All patient data and clinical results are processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is ISO 9001:2015 certified (Certificate No. INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Plasma Cell Dyscrasia Flow Cytometry Panel (Bone Marrow) |
| Price (AED) | 1,800 AED |
| Turnaround Time | 1–2 business days |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multicolor Immunophenotyping – 10-Color Flow Cytometry (EuroFlow Consensus) |
| ICD-10-CM Code | C90.00 (Multiple myeloma not having achieved remission) |
| LOINC Code | 85327-2 (Plasma cell dyscrasia panel - Bone marrow) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians